Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyDavid S. Ettinger, Miranda Hughes, Lucian R. Chirieac et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 1.4k
Non–Small Cell Lung Cancer, Version 4.2024Gregory J. Riely, Lisa Hang, Douglas E. Wood et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 746
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023David S. Ettinger, Miranda Hughes, Douglas E. Wood et al.|Journal of the National Comprehensive Cancer Network|2023Cited by 480
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey Liveringhouse, Bradford A. Perez, Kujtim Latifi et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 18